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N5-Phosphonoacetyl-l-ornithine (PALO, 1) is a bisubstrate 
transition-state analog which competitively inhibits ornithine 
transcarbamylase (OTC) in vitro, blocking biosynthesis of ci-
trulline in both the urea and the arginine biosynthetic path-
ways (Figure 1). 1, 2 Competitive inhibitors of amino acid me-
tabolism have been key components in studies ranging from 
arginine starvation in fungi and bacteria to studies on OTC de-
ficiency. 3, 4 
PALO has been tested as a potential tool for in vivo meta-
bolic studies. It failed to inhibit citrulline biosynthesis in iso-
lated rat mitochondria or intact rat hapatocytes,5 and did not 
inhibit growth of the bacterium Escherichia coli.6 These failures 
were attributed to the inability of PALO to cross cell mem-
branes. In contrast, Kinney and Lusty showed that PALO in-
duced arginine limitation in the yeast Saccharomyces cerevisiae.4 
The regulation of arginine metabolism in fungi is particularly 
important to understand because of the role of this amino acid 
in protein synthesis, as a nitrogen source and in signaling. 2, 
7–10 We now report a short and scalable synthesis of PALO, as 
well as results of investigations into the influence of PALO on 
growth and arginine metabolism in S. cerevisiae.
The first syntheses of PALO employed the direct func-
tionalization of copper-complexed ornithine. This strategy, 
while rapid, requires a significant set of purification steps. 1, 2, 
5, 11 Several more traditional routes begin with partially pro-
tected derivatives of ornithine, 3, 5 some of which are no lon-
ger commercially available. As illustrated in Scheme 1, we 
found that temporary masking of the amino acid of ornithine 
as the boroxazolidinone derivative enables a rapid and scal-
able synthesis of PALO in highly pure form. Reaction of l-
ornithine with 9-borabicyclononane (9-BBN) furnished the 
corresponding boroxazolidinone, 12, 13 which was directly con-
densed with dibenzylphosphonoacetic acid (2) to furnish am-
ide 3.14 We were unable to achieve deprotection of the boroxa-
zolidinone with aq HCl or methanolic ethylenediamine,12 even 
though these conditions were successfully modeled on the cor-
responding adduct of phenylalanine.15 Fortunately, dissolu-
tion of 3 in MeOH/CHCl3 resulted in slow but clean deprot-
ection to amino acid 4.16 Hydrogenolysis of the benzyl esters 
proceeded nearly quantitatively to furnish PALO (1) as a neu-
tral molecule which was pure by 1H, 13C, and 31P NMR. The 
PALO·NH4 salt could be prepared by elution from an ion-ex-
change column.
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Abstract
A scalable four-step synthesis of the ornithine transcarbamylase inhibitor N5-phosphonoacetyl-l-ornithine (PALO) is achieved 
through boroxazolidinone protection of ornithine. Investigations in the model organism Saccharomyces cerevisiae found that, in 
contrast to a previous report, PALO did not influence growth rate or expression of genes involved in arginine metabolism.
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Figure 1. PALO; OTC-catalyzed synthesis of citrulline.
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Kinney and Lusty reported that PALO increased expres-
sion of CPA1, CPA2, HIS3, and TRP5 reporter constructs in the 
yeast S. cerevisiae.4 The data were consistent with limitation of 
arginine leading to specific up regulation of arginine biosyn-
thetic genes (CPA1 and CPA2), and a general amino acid star-
vation response typified by up regulation of HIS3 and TRP5.
We tested whether treatment with PALO resulted in 
changes in mRNA accumulation and/or translation of genes 
involved in amino acid biosynthesis. We examined expres-
sion of two genes required for arginine biosynthesis; ARG5,6, 
which encodes a protein involved in the second and third 
steps of arginine biosynthesis from glutamate, and CPA1, 
which encodes a subunit of arginine-specific carbamyl-phos-
phate synthetase. Both of these genes are up regulated specif-
ically in response to arginine limitation. Expression of TRP5, 
which encodes an enzyme that catalyzes the final step in tryp-
tophan biosynthesis, was also examined as an indicator of the 
general amino acid starvation response. Quantitative north-
ern analysis was performed to measure mRNA abundance, a 
measure of the combined rates of transcription and mRNA de-
cay. Western analysis was used to look at the level of protein 
synthesis for these genes. This combined approach enabled di-
rect evaluation of effects on transcription, mRNA stability, and 
translation.
Although the yeast strains from the earlier studies were 
not available,4 they were derived from the W303 genetic back-
ground, which usually carry the can1-100 mutation.17 As 
CAN1 encodes an arginine permease required for efficient up-
take of arginine, the can1-100 mutation is not well suited for 
the current experiments. As a compromise, and to assess if 
PALO will be generally useful as a metabolic tool in S. cere-
visiae, the current data was obtained using the BY4741 strain 
of S. cerevisiae.18 This strain is derived from S288C, the strain 
used in the systematic sequencing project, and it is the most 
commonly used genetic background for genome-wide func-
tional analyses.
If PALO affects transcription or mRNA stability, we ex-
pected to observe an increase in expression of ARG5,6, CPA1, 
and TRP5 mRNA transcripts in the presence of PALO. We also 
expected that addition of arginine would relieve the arginine 
limitation induced by PALO. Cells were grown and treated 
with either 15 μM of the synthesized PALO, 1 mg/mL l-argi-
nine, or 15 μM of the synthesized PALO and 1 mg/mL l-argi-
nine as described by Kinney and Lusty.4 An untreated culture 
was grown in the same media as a control. The abundance of 
ARG5,6, CPA1, and TRP5 mRNAs was measured by quantita-
tive northern analysis (Figure 2A). The abundance of ARG5,6, 
CPA1, and TRP5 mRNAs in the PALO treated cells was not 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
significantly different from the untreated cells. The abun-
dance of ARG5,6 and CPA1, but not TRP5 mRNAs was lower 
in cells treated with arginine regardless of whether the cells 
were treated with PALO or not. Additionally, the abundance 
of the TRP5 transcript did not show any variation in response 
to addition of PALO, arginine or both. In summary treatment 
with PALO had no effect on the abundance of ARG5,6, CPA1 
or TRP5 mRNAs.
The possible effect of PALO on translation was investi-
gated by western analysis (Figure 2B). If PALO affects trans-
lation, we expected to see an increase in the production of 
Arg5,6p, Cpa1p, and Trp5p in the presence of PALO. We also 
expected that addition of l-arginine would reduce protein lev-
els of Arg5,6p and Cpa1p, but not Trp5p. We used cell ex-
tracts from strains (YSC1178-7500224, YSC1178-7502950 and 
YSC1178-7500415, respectively) carrying TAP-tagged alleles 
of ARG5,6, CPA1 and TRP5 for the western analysis. These 
strains produce a TAP-fusion protein for each gene which can 
be detected on western blots with anti-TAP antibodies. BY4741 
was used as an untagged control because it is the parent strain 
for the TAP-tagged strains. Cells were grown and treated in 
the same manner as for the northern analysis. Measurement of 
the signal intensity of the bands detected by western blotting 
revealed no difference in the production of Arg5,6p, Cpa1p, or 
Trp5p between strains treated with 15 μM PALO and the con-
Scheme 1. Synthesis of PALO (1).
Figure 2. PALO has no effect on expression of the ARG5,6, CPA1, and 
TRP5 genes in Saccharomyces cerevisiae. S. cerevisiae strains 18, 19 were 
inoculated from a saturated culture into minimal medium supple-
mented with leucine, methionine, uracil and histidine. Cultures were 
treated with 15 μM PALO in a potassium phosphate pH 6.8 buffer, po-
tassium phosphate buffer pH 6.8 alone (untreated), 1 mg/mL l-argi-
nine, or both 15 μM PALO and 1 mg/mL l-arginine at the time of in-
oculation. Cells were incubated at 30 °C and then harvested at mid-log 
growth phase (OD600 0.4–0.6). (A) Northern blots were prepared with 
total RNA extracted from BY4741 18, 19 and probed with oligolabeled 
DNA probes.20 DNA probes were generated using primer sets for am-
plifying yeast open reading frames based on the sequences available 
from the Saccharomyces Genome Database. Shown are representative 
phosphorimages of a northern blot probed with radioactive ARG5,6, 
CPA1, TRP5, and SCR1 DNAs. SCR1 was used as a loading control. 
Quantitative results depicted are the average of three replicate trials 
and are normalized to the SCR1 loading control. (B) Western blots were 
prepared using protein extracts from S. cerevisiae YSC1178-7500224, 
YSC1178-7502950 and YSC1178-7500415 strains19 expressing TAP-fu-
sion proteins Arg5,6-TAP, Cpa1-TAP, and Trp5-TAP, respectively, as 
well as BY4741 (untagged control). 21, 22 The TAP-tagged proteins were 
detected using an anti-TAP antibody. No proteins bound the anti-TAP 
antibody in the untagged control. Duplicate polyacrylamide gels were 
stained with Coomassie blue for use as loading controls. The corre-
sponding loading controls are shown beneath the western blots.
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trol. As expected, addition of l-arginine reduced production of 
Arg5,6p and Cpa1p, but not of Trp5p regardless of whether 
PALO was added or not. In summary, PALO had no effect on 
Arg5,6p, Cpa1p, and Trp5p protein levels.
PALO did not affect the growth rate of BY4741 in minimal 
media or nitrogen-limiting medium (data not shown), used in 
an attempt to increase sensitivity to PALO by lowering intra-
cellular arginine concentrations. Growth in nitrogen-limiting 
medium induces cells to use amino acids, including arginine, 
as a source of nitrogen. These findings were consistent with 
the observations reported by Kinney and Lusty.4
In conclusion, we have developed an efficient synthesis of 
very pure PALO by a route suitable for both analytical and 
preparative applications. In contrast to a previous report de-
scribing PALO-induced arginine starvation,4 we observed no 
response in S. cerevisiae strain BY4741 to treatment with PALO 
(Figure 2). The discrepancy suggests either that not all yeast 
strains are sensitive to PALO or that the earlier indications of 
arginine starvation resulted from impurities in the samples of 
PALO employed. The current results are consistent with ob-
servations that PALO had no effect in isolated rat mitochon-
dria, intact rat hepatocytes or E. coli. 5, 6 
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General Experimental Conditions: 2 
 
L-ornithine, 9-borabicyclononyl coordination compound: 2 
 
Dibenzylphosphonoacetic acid (2): 2 
 
N5-([2-Dibenzyloxyphosphinyl)acetyl])-L-ornithine, 9-BBN adduct (3): 2 
 
N5-([2- Dibenzyloxyphosphinyl)acetyl])-L-ornithine (4)  2 
 
N5-(2-Phosphonoacetyl)- L-ornithine (PALO)  (1): 3 
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Dibenzyl methyl phosphonate  (1H, 13C, 31P) p 4-6 
 
Dibenzylphosphonoacetic acid (2;  1H, 13C, 31P) p 7-9 
 
N5-([2-Dibenzyloxyphosphinyl)acetyl])-L-ornithine, 9-BBN adduct (3; 1H, 13C, 31P) p 10-12 
 
N5-([2- Dibenzyloxyphosphinyl)acetyl])-L-ornithine (4; 1H, 13C, 31P) p 13-15 
 
N5-(2-Phosphonoacetyl)- L-ornithine (PALO)  (1; 1H, 13C, 31P) p 16-18 
 
General Experimental Conditions: Reagents and solvents were used as supplied commercially, except THF, 
which was distilled from Na/Ph2CO, and methanol, which was distilled from Mg/I2. 1H, 13C, and 31P spectra 
were recorded in CDCl3 at 400, 100, and 121.5 MHz, respectively, unless noted. TLC was monitored via one or 
more of the following: UV; vanillin (charring); ninhydrin; bromocresol green.1  Mass spectra were obtained at 
the Nebraska Center for Mass Spectrometry. 
Synthesis of PALO: 
L-ornithine, 9-borabicyclononyl coordination compound was prepared using a reported procedure,2 except 
that L-ornithine•HCl (4.22 g, 25 mmol) was added before the reaction was brought to reflux. The crude product 
was often obtained as a viscous yellow-brown oil rather than the reported gummy solid. Washing of the crude 
product with ether, followed by drying under high vacuum, furnished a white powder (5.82 g, 92 %) which was 
used without further purification. HRMS m/z calcd. for C13H26BN2O2 (M+): 253.20873; found: 253.20774 (3.9 
ppm); [α]: -5.2° (c 2.0, MeOH). 
Dibenzylphosphonoacetic acid (2) was prepared in two steps.3  Alkylation of dibenzylphosphite (5.23 g, 20 
mmol) with MeI furnished dibenzyl methyl phosphonate (3.83 g, 69%).The residue obtained from filtration and 
concentration was purified by flash chromatography (Rf = 0.34, 1:1 EA/hex). Spectra were identical to the 
previous report,3 with the following exceptions: 1H signals reported at 4.90-5.2 were resolved as 5.08 and 4.98 
(dd, each 2H, J = 8.3-8.9 and 11.8 Hz, 3JH-P coupling); 13C NMR, 136.4 (d, 3JCP = 6.1 Hz), 128.6, 128.4, 127.9, 
67.1 (d, 2JCP = 6.2 Hz), and 11.7 (d, 1JCP = 144 Hz); 31P 31.7; HRMS m/z calcd. for C15H17O3P (M+H)+: 
277.099358; found 277.10021 (3.1 ppm). 
In the second step,3 carboxylation of the phosphonate (2.76 g, 10 mmol) with CO2-saturated ether furnished 2 
(1.85 g, 58%), which was sufficiently pure to be used directly. A sample was purified by chromatography in 
EA/hex (Rf = 0.70, EA). Spectral data were identical to those previously reported,3 with the following 
exceptions or additions:  the 1H multiplet reported at 5.08 ppm was resolved into two dd [5.12 and 5.08, each dd, 
2H, 9.1, 17.3 Hz, with the latter due to 3JHP coupling); 13C NMR 167.8 (d, 3JCP = 5.3 Hz) 135.7, 128.6, 128.1, 
68.6 (d, JCP = 6.3 Hz), 34.5 (d, 1JCP = 136 Hz); 31P NMR 22.2; IR (film) v 3200-2500, 1720, 1210, 990, 730, 
695 cm-1; HRMS m/z calcd. for C16H21O3P (M+H)+: 321.08919; found: 321.08806 (3.5 ppm). 
N5-([2-Dibenzyloxyphosphinyl)acetyl])-L-ornithine, 9-borabicyclononane adduct (3):  In an N2-flushed, 
oven-dried, 50 mL round bottom flask was added dry THF (33 mL) and 9-BBN-protected L-ornithine (1.31 g, 
5.2 mmol). The mixture was stirred until homogeneous whereupon 2 (1.50 g, 4.7 mmol), dimethyl 
aminopyridine (0.574 g, 4.7 mmol), and dicyclocarbodiimide (1.07 g, 5.2 mmol) were added. The reaction was 
stirred overnight at rt, resulting in a suspension. The residue obtained upon concentration was re-suspended in 
ethyl acetate and filtered. The filtrate was sequentially washed with sat. aq. NaHCO3 (2 x 15 mL), water (15 
mL), 1 M HCl (2 x 15 mL), and water (15 mL). The organic layer was dried with anhydrous Na2SO4 and 
filtered. The residue obtained upon concentration was purified by flash chromatography (Rf = 0.40, 1% 
MeOH/EA) to yield 3 as a white solid (1.61 g, 2.9 mmol, 62%); 1H NMR 7.30 – 7.38 (m, 10H), 6.78 (t, 1H, J = 
5.7 Hz), 5.31 (dd, 1H, J = 8.0 Hz, J = 11.6 Hz), 4.92-5.06 (m, 5H), 3.62-3.69 (m, 1H), 3.34-3.43 (m, 1H), 3.08-
3.16 (m, 1H), 2.86 (d, 2H, J = 21.0 Hz), 1.41-2.10 (m, 16H), and 0.59 (d, 2H, J = 12.0 Hz); 13C NMR 174.4, 
135.5, 128.8, 128.0, 68.3, 54.9, 38.9, 31.4, 28.0, 24.1; 31P NMR (75.5 MHz) 23.3; IR (solid) v 3292, 3174, 3108, 
2923, 2877, 2838, 1692, 1664, 1240, 1214, 1008, 998, 724 cm-1; HRMS m/z calcd. for C29H40BN2O6P (M+): 
555.27953; found: 555.27801 (2.7 ppm); [α]: -13.4° (c 2.0, CHCl3); MP = 125-129° C.  
N5-([2- Dibenzyloxyphosphinyl)acetyl])-L-ornithine (4): Into a ~25 mL vial was added 3 (120 mg, 0.22 
mmol), methanol (200 µL), and CHCl3 (10 mL).4 The reaction was stirred at rt for 72 hours and monitored by 
TLC (Rf = 0.50 on C18 RP-TLC plates in 3:1 MeOH/H2O, developed with ninhydrin). Once the reaction 
appeared to be complete, the solution was concentrated to an oil, purified by ion exchange (~2 g Dowex 50X2-
200; column – 1.5 cm x 30 cm, pre-acidified with 2M HCl, eluting solvent: 1% NH4OH), and lyophilized to 
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yield 4 as a fluffy, white solid (85.6 mg, 0.20 mmol, 90%). 1H NMR (MeOH) 7.39-7.32 (m, 10H), 5.09 (dd, 2H, 
J = 11.8, 11.4 Hz; ABX  w/5.04 ppm), 5.04 (dd, 2H, J = 11.8, 11.4 Hz; ABX w/ 5.09 ppm), 3.53 (dd, 1H, J = 
6.6, 6.6 Hz), 3.27-3.14 (m, 2H), 3.02 (d, 2H, J = 21.7 Hz), 1.93-1.75 (m, 2H), and 1.66-1.57 (m, 2H); 13C NMR 
(MeOD) 174.4, 137.7, 129.8, 129.8, 129.3, 69.7, 55.9, 40.4, 37.0, 35.5, 29.9, and 26.3; 31P NMR (162 MHz, 
MeOD) 24.1; IR (solid) 3350-3250, 3150-2800, 1630, 1550, 1230, 995, 900, 825, and 670 cm-1; HRMS m/z 
calcd. for C21H28N2O6P (M+H)+: 435.16850; found: 435.16846 (0.1 ppm); [α]: +1.2° (c 2.1, MeOH); MP = 167-
170°C. 
N5-(2-Phosphonoacetyl)- L-ornithine (PALO, 1): Phosphonate 4 (133 mg, 0.3 mmol was mixed with formic 
acid (1.1 mL) and 10% Pd/C (54 mg, 28 mol %) in a N2-flushed vial. The vial was capped with a rubber septum 
and the mixture stirred for 5 min while being flushed with nitrogen. The mixture was then placed under an atm 
of H2 (balloon) and the headspace briefly vented (needle) to purge N2. The reaction was stirred for 24 h and then 
filtered through a plug of Celite. The filtrate was lyophilized, yielding a white solid (72 mg, 95 %) that 
deformed at ~ 70 °C. 1H NMR (300 MHz, D2O) 4.00 (t, 1H, J = 5.9 Hz), 3.26 (t, 2H, J = 5.9 Hz), 2.75 (d, 2H, 
2JH-P = 20.4 Hz), 2.08 (m, 2H), 1.54 (m, 2H)  ; 13C NMR (75.5 MHz, D2O) 172.69, 170.22, 53.10, 38.67, 38.42 
(d, J = 122 Hz), 27.24, and 24.10; 31P NMR (121.5 MHz, D2O) 15.0; IR (solid) v 3600-2350, 1715, 1630, 1547, 
1300, 1204, 1020, and 915; HRMS m/z calcd. for C6H13N2O6P (M+H)+: 255.074600; found: 255.074685 (0.3 
ppm); [α]: +3.6° (c 1.0, H2O). 
 
 
1. Handbook of Thin-Layer Chromatography (Chromatographic Science, Vol. 89), Sherma, J.; Fried, B., 
Eds., Marcel Dekker, New York, 2003. 
2. Fields, S. C.; Dent III, W. H.; Erickson, R. Parker, M. H., Tromiczak, E. G.  Org. Lett.  2002, 4, 1249. 
3. Koppel, G. A.; Kinnick, M. D. Tetrahedron Lett.  1974, 9, 711-13; Grison, C., Coutrot, P., Comoy, C., 
Balas, L., Joliez, S., Lavecchia, G., Oliger, P., Penverne, B., Serre, V., Herve, G. Eur. J. Med. Chem. 
2004, 39, 333. 
4. Walker, W. H. IV.; Rokita, S. E. J. Org. Chem. 2003, 68, 1563; Syed, B. M.; Gustafsson, T; Kihlberg, 
J.  Tetrahedron, 2004, 60, 5571. We are also unable to explain the deprotection, but note that it is 
unaffected by oxygen, catalytic acid, or catalytic base. 
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